Serum indicators of free radical activity in idiopathic pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1918-1923

  Jack, Catherine I A ^a   Jackson, Malcolm J ^b   Johnston, Ian D A ^b   Hind, Charles R K ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL;

ADULT; ARTICLE; BLOOD LEVEL; CHELATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IRON BLOOD LEVEL; LIPID PEROXIDATION; LUNG FIBROSIS; MALE; PRIORITY JOURNAL;

EID: 0029951895     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665056     Document Type: Article

References (36)

1. Crystal, R. G., P. B. Bitterman, S. I. Rennard, A. J. Hance, and B. A. Keogh. 1984. Interstitial lung disease of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N. Engl. J. Med. 310:154-166, 235-244.
2. Tukiainen, P., E. Taskinen, P. Holsti, O. Korhola, and M. Valle. 1983. Prognosis of cryptogenic fibrosing alveolitis. Thorax 38:349-355.
3. Johnston, I., J. Britton, W. Kinnear, and R. Logan. 1990. Rising mortality from cryptogenic fibrosing alveolitis. B. M. J. 301:1017-1021.
4. Henson, P. M. 1986. Mechanisms of cellular injury in interstitial lung disease. Chest 89:108S-111S.
5. Strausz, J., J. Muller-Quernheim, H. Steppling, and R. Ferlinz. 1990. Oxygen radical production by alveolar inflammation cells in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 141:124-128.
6. Daniele, R. P., J. A. Elias, P. E. Epstein, and M. D. Rossman. 1985. Bronchoalveolar lavage: role in the pathogenesis, diagnosis and management of interstitial lung disease. Ann. Intern. Med. 102:93-108.
7. Snider, G. L. 1983. Interstitial pulmonary fibrosis: which cell is the culprit? Am. Rev. Respir. Dis. 127:535-539.
8. Malech, H. L., and J. I. Gallin. 1987. Neutrophils in human diseases. N. Engl. J. Med. 317:687-694.
9. Tate, R. M., K. M. Vanbenthuysen, R. M. Tate, S. S. Shasby, I. F. McMurty, and J. E. Repine. 1982. Granulocytes mediate acute oedematous lung injury in rabbits and isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen free radicals. Am. Rev. Respir. Dis. 125:443-447.
10. Borzi, R. M., B. Grigolo, R. Meliconi, L. Fasano, C. Sturani, M. Fabbri, T. Porstmann, and A. Facchini. 1993. Elevated serum superoxide dismutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosis. Clin. Sci. 85:353-359.
11. Babior, B. M., R. S. Kipnes, and J. T. Curnutte. 1973. The production by leukocytes of superoxide, a potential bacterocidal agent. J. Clin. Invest. 52:741-744.
12. Cantin, A. M., R. C. Hubbard, and R. G. Crystal. 1989. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139:370-372.
13. Jack, C. I. A., M. J. Jackson, and C. R. K. Hind. 1994. Circulating markers of free radical activity in patients with pulmonary fibrosis. Tuber. Lung Dis. 75:132-137.
14. Johnston, I. D. A., S. A. Gomm, S. Kalra, A. A. Woodcock, C. C. Evans, and C. R. K. Hind. 1993. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur. Respir. J. 6:891-893.
15. Scadding, J. G., and K. F. W. Hinson. 1967. Diffuse fibrosing alveolitis (diffuse interstitial of the lungs): correlation of histology at biopsy with prognosis. Thorax 22:291-304.
16. Watters, L. C., T. E. King, M. I. Schwarz, J. A. Waldron, R. E. Stanford, and R. M. Cherniack. 1986. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 133:97-103.
17. Turner-Warwick, M., and P. L. Haslam. 1987. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am. Rev. Respir. Dis. 135:26-34.
18. Iversen, S. A., P. Cawood, and T. L. Dormandy. 1985. A method for the measurement of a diene-conjugated derivative of linoleic acid 18:2(9,11), in serum phospholipid, and possible origins. Ann. Clin. Biochem. 22:137-140.
19. Yagi, K. 1989. A simple fluorometric assay for lipid peroxides in blood serum or plasma. In CRC Handbook of Biomedicine of Free Radicals and Antioxidants, Vol 3. 215-217.
20. Gower, J., G. Healing, and C. Green. 1989. Measurement by HPLC of desferrioxamine-available iron in rabbit kidneys to assess the effect of ischaemia on the distribution of iron within the total pool. Free Radic. Res. Commun. 5:291-299.
21. Pepys, M. B., and M. L. Baltz. 1983. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34:141-212.
22. Lunec, J., S. P. Halloran, A. G. White, and T. L. Dormandy. 1981. Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J. Rheumatol. 8:233-245.
23. Grech, E. D., C. I. A. Jack, C. Bleasdale, M. J. Jackson, M. Baines, E. B. Faragher, C. R. K. Hind, and R. A. Perry. 1993. Differential free-radical activity after successful and unsuccessful thrombolytic reperfusion in acute myocardial infarction. Coron. Artery Dis. 4: 769-774.
24. Fairbank, J., A. Hollingworth, J. Griffin, E. Ridgway, D. Wickens, A. Singer, and T. Dormandy. 1989. Octadeca-9,11-dienoic acid in cervical intraepithelial neoplasia: a colposcopic study. Clin. Chim. Acta 186:53-58.
25. Jack, C. I. A., M. J. Jackson, E. Ridgway, and C. R. K. Hind. 1994. Serum octadeca-9,11 dienoic acid: an assay of free radical activity or a result of bacterial production? Clin. Chim. Acta 224:139-146.
26. Wickens, D. G., J. F. Griffin, E. R. Maher, J. R. Curtis, and T. H. Dormandy. 1987. The effect of systematic heparinisation and haemodialysis on plasma octadeca-9,11-dienoic acid (9,11-LA′). Free Radic. Res. Commun. 3:99-106.
27. Britton, M., C. Fong, D. Wickens, and J. Yudkin. 1992. Diet as a source of phospholipid esterified 9,11-octa-decadienoic acid in humans. Clin. Sci. 83:97-101.
28. Aisen, P., and I. Listowsky. 1980. Iron transport and storage proteins. Annu. Rev. Biochem. 49:357-393.
29. Gutteridge, J. M. C., and B. Halliwell. 1987. Radical-promoting loosely-bound iron in biological fluids and the bleomycin assay. Life Chem. Rep. 4:113-142.
30. Blake, D. R., P. J. Gallagher, A. R. Potter, M. J. Bell, and P. A. Bacon. 1984. The effect of synovial iron on the progression of rheumatoid disease. Arthritis Rheum. 27:495-501.
31. Halliwell, B., and J. M. C. Gutteridge. 1984. Role of iron in oxygen radical production. Methods Enzymol. 105:47-56.
32. Halliwell, B., J. M. C. Gutteridge. 1989. In B. Halliwell and J. M. C. Gutteridge, editors. Free radicals in Biology and Medicine, 2nd ed. Clarendon Press, Oxford. 22-85.
33. Brown, K. M., P. C. Morrice, and G. G. Duthie. 1994. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and non-smokers but plasma lipoprotein concentrations remain unchanged. Am. J. Clin. Nutr. 60:383-387.
34. Gutteridge, J. M. C., and Y. Hou. 1986. Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron. Free Radic. Res. Commun. 2:143-151.
35. Longmire, A. W., L. L. Swift, L. J. Roberts, J. A. Awad, R. F. Burk, and J. D. Morrow. 1994. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem. Pharmacol. 47:1173-1177.
36. Borok, Z., R. Buhl, G. J. Grimes, A. D. Bokser, R. C. Hubbard, K. J. Holroyd, J. H. Roum, D. B. Czerski, A. M. Cantin, and R. G. Crystal. 1991. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338:215-216.